The Net Margin of Keros Therapeutics Inc (KROS) is -5277.55%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -5277.55% |
| 2023-12-31 | -101319.21% |
| 2022-12-31 | -292.24% |
| 2021-12-31 | -123.40% |
| 2020-12-31 | -13.40% |